Brain insulin plays critical role in development of diabetes
February 17th, 2011 - 1:50 pm ICT by ANIWashington, Feb 17 (ANI): Scientists have discovered a novel function of brain insulin.
Researchers from Mount Sinai School of Medicine have discovered that impaired brain insulin action may be the cause of the unrestrained lipolysis that initiates and worsens type 2 diabetes in humans.
Led by Christoph Buettner, Assistant Professor of Medicine in the Division of Endocrinology, Diabetes and Bone Disease at Mount Sinai School of Medicine, the research team first infused a tiny amount of insulin into the brains of rats and then assessed glucose and lipid metabolism in the whole body. In doing so, they found that brain insulin suppressed lipolysis, a process during which triglycerides in fat are broken down and fatty acids are released.
Furthermore, in mice that lacked the brain insulin receptor, lipolysis was unrestrained. While fatty acids are important energy sources during fasting, they can worsen diabetes, especially when they are released after the person has eaten, as happens in people with diabetes. Researchers previously believed that insulin’s ability to suppress lipolysis was entirely mediated through insulin receptors expressed on adipocytes, or fat tissue cells.
“The major lipolysis-inducing pathway in our bodies is the sympathetic nervous system and here the studies showed that brain insulin reduces sympathetic nervous system activity in fat tissue. In patients who are obese or have diabetes, insulin fails to inhibit lipolysis and fatty acid levels are increased. The low-grade inflammation throughout the body’s tissue that is commonly present in these conditions is believed to be mainly a consequence of these increased fatty acid levels.”
Buettner added, “When brain insulin function is impaired, the release of fatty acids is increased. This induces inflammation, which can further worsen insulin resistance, the core defect in type 2 diabetes. Therefore, impaired brain insulin signaling can start a vicious cycle since inflammation can impair brain insulin signaling.
” This cycle is perpetuated and can lead to type 2 diabetes. Our research raises the possibility that enhancing brain insulin signaling could have therapeutic benefits with less danger of the major complication of insulin therapy, which is hypoglycemia.”
The research is published in the journal Cell Metabolism. (ANI)
- Human enzyme holds promise of weight loss - Nov 15, 2011
- Link between high-fat diets, type 2 diabetes clarified - Apr 12, 2011
- How fish oils work against diabetes - Sep 03, 2010
- Brain-hormone circuit that helps police diabetes, female fertility unraveled - Apr 09, 2010
- Brain chemical that regulates mood may have anti-diabetic properties - Nov 14, 2010
- Brain chemical that regulates mood may have anti-diabetic properties too - Nov 11, 2010
- Heart hormone helps shape fat metabolism - Feb 07, 2012
- Protein that modulates metabolic dysfunction in obesity identified - Jun 18, 2010
- Insulin reduces obesity-related inflammation - May 11, 2010
- Common dairy foods may cut diabetes risk - Dec 21, 2010
- Fatty liver 'independently increases Type 2 diabetes risk' - Feb 25, 2011
- Potential new non-insulin treatment for type 1 diabetes found - Mar 25, 2011
- Plant oil may be a key in the fight against obesity - Mar 24, 2011
- Root cause of blood vessel damage in people with diabetes discovered - Jan 29, 2011
- Resveratrol can reduce body fat: Study - Mar 05, 2011
Tags: acid levels, bone disease, brains of rats, diabetes insulin, diabetes researchers, fatty acids, function of brain, insulin action, insulin receptor, insulin receptors, insulin resistance, lipid metabolism, lipolysis, mount sinai school, mount sinai school of medicine, nervous system activity, novel function, sympathetic nervous system, tissue cells, type 2 diabetes